Good Reminder - Possible Delisting - from the press release

Remedial Delisting Review

As previously reported, as a result of the Company’s reliance upon the financial hardship exemption in connection with the Company’s previously-announced $87 million private placement with Shenzhen Hepalink Pharmaceutical Co. Ltd., the TSX commenced an automatic remedial de-listing review, which is normal practice when a listed issuer relies on this exemption. The Company anticipates further improving its financial position by raising additional capital. The Company has received a 60-day extension to April 12, 2018 for the TSX’s review of the Company’s compliance with all of the TSX listing requirements.

I forgot about this. As I recall Don spoke of this as just a standard requirement by the TSX and I thought it is no big deal.

However, does anyone one know what the TSX requires from RVX in order to retain it's TSX listing? The release states that the company anticipates improving it's financial position. I'm not sure exactly what this means but it seems to imply that RVX is required to prove that it will remain an ongoing business. If the company is going to improve it's financial position it appears they must do it before April 12th (good news if successful) OR perhaps they can get another TSX extension?

As a shareholder it would not be good to lose the liquidity that the listing provides.

Apologies if this issue has been discussed and resolved.

It seems like some time issues are converging like the SSA/FA, funding and the TSX listing. New financing would relieve significant pressure points, particularly if the financing makes a strong statement about a vote of confidence in apabetalone.

Thoughts?

GLTA

Toinv

bbbbbb